GSK raised its full-year guidance after second quarter core earnings rose 13%, helped by higher sales in oncology, HIV and its general medicines portfolio.
Related Posts
Financial Services Roundup: Market Talk
Read about UniCredit, Commerzbank and more in the latest Market Talks covering Financial Services.
CBS Interview on Israel Triggers Fight at Network; Shari Redstone Weighs In
An anchor critiqued Ta-Nehisi Coates’s new book, and Paramount’s controlling shareholder objected to how the network handled the matter.
Seoul Semiconductor’s Patent Case Leads to LED Sales Ban in Eight European Countries
The United Patent Court’s ruling also orders German online retailer to retrieve and destroy all such LED goods already sold in the region.